Business Wire
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
📈
AI Sentiment
Highly Positive
9/10
- Home
- SRTS
as of 02-18-2026 3:38pm EST
$3.82
$0.01
-0.26%
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
| Founded: | 2010 | Country: | US |
| Employees: | N/A | City: | BOCA RATON |
| Market Cap: | 79.3M | IPO Year: | 2016 |
| Target Price: | $6.67 | AVG Volume (30 days): | 109.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.28 | EPS Growth: | 1266.67 |
| 52 Week Low/High: | $3.03 - $5.92 | Next Earning Date: | 05-12-2026 |
| Revenue: | $41,807,000 | Revenue Growth: | 71.31% |
| Revenue Growth (this year): | 31.8% | Revenue Growth (next year): | 32.01% |
| P/E Ratio: | -13.80 | Index: | N/A |
| Free Cash Flow: | -1107000.0 | FCF Growth: | N/A |
AI-Powered SRTS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 78.67%
78.67%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Sensus Healthcare Inc. (SRTS)
Sachetta Eric
Buy
Director
SRTS Nov 21, 2025
Avg Cost/Share
$3.93
Shares
7,000
Total Value
$27,510.00
Owned After
140,113
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Sachetta Eric | SRTS | Director | Nov 21, 2025 | Buy | $3.93 | 7,000 | $27,510.00 | 140,113 |
Latest Sensus Healthcare Inc. News
SRTS Breaking Stock News: Dive into SRTS Ticker-Specific Updates for Smart Investing
Simply Wall St.
Sensus Healthcare, Inc. (NASDAQ:SRTS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
📉
AI Sentiment
Negative
3/10
GuruFocus.com
Sensus Healthcare Inc (SRTS) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...
📊
AI Sentiment
Positive
6/10
Business Wire
Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer
âž–
AI Sentiment
Neutral
4/10
Simply Wall St.
Sensus Healthcare (NASDAQ:SRTS) shareholders have endured a 36% loss from investing in the stock three years ago
📉
AI Sentiment
Negative
3/10
Compare SRTS vs Leading Stocks
See how SRTS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SRTS Sensus Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.